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Prenatal screening processes are important public health
interventions to counter common genetic disorders. For
India prenatal screening against neural tube defects, tha-
lassemia and Down syndrome is relevant to the health
needs. However, there are many misconceptions regard-
ing the principles of screening. Many clinicians wrongly
consider it as substitute for prenatal diagnosis. Basically,
prenatal screening protocols can be applied on a wide
scale to identify women at risk of bearing a child with
the common genetic disorder in that population.
Prenatal screening for Down syndrome and other
chromosomal abnormalities is a rapidly evolving science.
It initially started with offering prenatal diagnosis to
elderly mothers. The identification of low maternal
serum alpha-fetoprotein levels as a marker in Down syn-
drome led to quest and recognition of many serum mar-
kers and maternal serum markers of AFP uE3 and hCG
were used in combination as triple test and with addi-
tion of Inhibin as the quadruple test. The identification
of Nuchal translucency as a marker in 1st trimester led
to much desired early risk prediction along with PaPPA
and free beta hCG. It was also found that this test led
to early risk determination and an early prenatal diagno-
sis with significantly better detection rate of 85 to 90%.
This detection rate is head and shoulders better than
the detection rate for the triple test rate of 65 to 70%.
It has also been noted that combination of these mar-
kers can also lead to risk prediction of other chromosomal
abnormalities. Presently risk prediction is possible with
some remarkable softwares for Trisomy 18, Trisomy 13,
Turner syndrome, triploidy, Cornela de Lange syndrome,
Smith Lemlie Opitz syndrome and others. New markers
like ADAM 12 with PaPPA will lead to early prediction of
PIH and IUGR as well as prematurity. It is envisaged that
in future maternal serum markers in combination with
fetal biometry will give risk prediction for numerous chro-
mosomal abnormalities many fetal disorders as well as
pregnancy disturbances. Thus prenatal screening has an
important place in antenatal care.
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